Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma
Clinical trial NCT00113217 · COMPLETED
Trial details
- NCT number
- NCT00113217
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2012-08-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.